Poly Medicure (Polymed), India's largest listed medical devices maker, is planning to invest ₹750 crore over 2 years on expansion of manufacturing plants and acquisitions to expand product basket.The company last month raised ₹1,000 crore through qualified institutional placement (QIP) and has ₹150 crore as free cash flow to fund its growth plans.Polymed makes disposable medical items, such as IV cannula, blood bags, blood collection tubes, and infusion and transfusion sets.

印度最大的上市医疗器械制造商Poly Medicure（Polymed）计划在两年内投资7.5亿欧元用于扩大制造工厂和收购，以扩大产品范围。该公司上月通过合格机构配售（QIP）筹集了10亿欧元，并拥有15亿欧元的自由现金流，为其增长计划提供资金。Polymed生产一次性医疗用品，如静脉插管、血袋、采血管、输液器和输血器。

About two-thirds of sales come from infusion therapy products. The company spends 2% of revenue on R&D.(You can now subscribe to our Economic Times WhatsApp channel)(You can now subscribe to our Economic Times WhatsApp channel).

大约三分之二的销售额来自输液治疗产品。该公司将收入的2%用于研发。（您现在可以订阅我们的经济时报WhatsApp频道）（您现在可以订阅我们的经济时报WhatsApp频道）。